Evidence map›Paper›PMID 34148116›Full record

ArticleHuman genetics2022

Unraveling the genetic complexities of combined retinal dystrophy and hearing impairment.

Paulina Bahena, Narsis Daftarian, Reza Maroofian, Paola Linares, Daniel Villalobos, Mehraban Mirrahimi, Aboulfazl Rad, Julia Doll, Michaela A H Hofrichter, Asuman Koparir and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Human genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Multidisciplinary approach to inherited causes of dual sensory impairment.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 12 institutions in 4 countries.

Paulina BahenaInstitute of Human Genetics, Julius Maximilians University Würzburg, 97074, Würzburg, Germany.
Narsis DaftarianOcular Tissue Engineering Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Reza MaroofianDepartment of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, UK.
Paola LinaresUniversidad Nacional Autónoma de México, Mexico City, Mexico.
Daniel VillalobosDepartment of Bioinformatics, University of Würzburg, Würzburg, Germany.
Mehraban MirrahimiOcular Tissue Engineering Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Aboulfazl RadDepartment of Otolaryngology-Head and Neck Surgery, Tübingen Hearing Research Centre, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.
Julia DollInstitute of Human Genetics, Julius Maximilians University Würzburg, 97074, Würzburg, Germany.
Michaela A H HofrichterInstitute of Human Genetics, Julius Maximilians University Würzburg, 97074, Würzburg, Germany.
Asuman KoparirInstitute of Human Genetics, Julius Maximilians University Würzburg, 97074, Würzburg, Germany.
Tabea RöderInstitute of Human Genetics, Julius Maximilians University Würzburg, 97074, Würzburg, Germany.
Seungbin HanInstitute of Human Genetics, Julius Maximilians University Würzburg, 97074, Würzburg, Germany.
Hamideh SabbaghiOphthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No. 23, Paidarfard St., Boostan 9 St., Pasdaran Ave., Tehran, 1666673111, Iran.
Hamid AhmadiehOphthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No. 23, Paidarfard St., Boostan 9 St., Pasdaran Ave., Tehran, 1666673111, Iran.
Hassan BehboudiAmiralmomenin Hospital, Eye Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Cristina Villanueva-MendozaGenetics Department, Asociación Para Evitar la Ceguera en México (APEC), Mexico City, Mexico.
Vianney Cortés-GonzalezGenetics Department, Asociación Para Evitar la Ceguera en México (APEC), Mexico City, Mexico.
Rocio Zamora-OrtizOphthalmic Department, Instituto de Seguridad y Servicios sociales de los Trabajadores del Estado, Hospital de Alta Especialidad, Puebla, Mexico.
Susanne KohlCentre for Ophthalmology, Institute for Ophthalmic Research, Eberhard Karls University Tübingen, Tübingen, Germany.
Laura KuehleweinCentre for Ophthalmology, Institute for Ophthalmic Research, Eberhard Karls University Tübingen, Tübingen, Germany.
Hossein DarvishFaculty of Medicine, Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Elham AlehabibStudent Research Committee, Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Maria de la Luz Arenas-SordoDepartment of Genetics, National Institute of Rehabilitation Luis Guillermo Ibarra (INR), Mexico City, Mexico.
Fatemeh Suri *Ophthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No. 23, Paidarfard St., Boostan 9 St., Pasdaran Ave., Tehran, 1666673111, Iran. fatemehsuri@gmail.com.
Barbara Vona *Institute of Human Genetics, Julius Maximilians University Würzburg, 97074, Würzburg, Germany. barbara.vona@uni-tuebingen.de.
Thomas Haaf *Institute of Human Genetics, Julius Maximilians University Würzburg, 97074, Würzburg, Germany. thomas.haaf@uni-wuerzburg.de.ORCID http://orcid.org/0000-0002-0737-0763
University of Würzburg · DEResearch Institute for Endocrine Sciences · IRShahid Beheshti University of Medical Sciences · IRAsociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes · MXSTZ eyetrial · DEGolestan University · IRGuilan University of Medical Sciences · IRHospital de Especialidades · MXInstituto Nacional de Rehabilitación · MXNational Hospital for Neurology and Neurosurgery · GBUniversidad Nacional Autónoma de México · MXUniversity of Tübingen · DE

Funding

Medizinischen Fakultät, Eberhard Karls Universität Tübingen 2545-1-0
6 · The paper itself

Abstract

Usher syndrome, the most prevalent cause of combined hereditary vision and hearing impairment, is clinically and genetically heterogeneous. Moreover, several conditions with phenotypes overlapping Usher syndrome have been described. This makes the molecular diagnosis of hereditary deaf-blindness challenging. Here, we performed exome sequencing and analysis on 7 Mexican and 52 Iranian probands with combined retinal degeneration and hearing impairment (without intellectual disability). Clinical assessment involved ophthalmological examination and hearing loss questionnaire. Usher syndrome, most frequently due to biallelic variants in MYO7A (USH1B in 16 probands), USH2A (17 probands), and ADGRV1 (USH2C in 7 probands), was diagnosed in 44 of 59 (75%) unrelated probands. Almost half of the identified variants were novel. Nine of 59 (15%) probands displayed other genetic entities with dual sensory impairment, including Alström syndrome (3 patients), cone-rod dystrophy and hearing loss 1 (2 probands), and Heimler syndrome (1 patient). Unexpected findings included one proband each with Scheie syndrome, coenzyme Q10 deficiency, and pseudoxanthoma elasticum. In four probands, including three Usher cases, dual sensory impairment was either modified/aggravated or caused by variants in distinct genes associated with retinal degeneration and/or hearing loss. The overall diagnostic yield of whole exome analysis in our deaf-blind cohort was 92%. Two (3%) probands were partially solved and only 3 (5%) remained without any molecular diagnosis. In many cases, the molecular diagnosis is important to guide genetic counseling, to support prognostic outcomes and decisions with currently available and evolving treatment modalities.

Indexed as

Retinal DegenerationUsher SyndromesHumansIranMutationPedigreePhenotype

Identifiers

PMID34148116
PMCPMC9035000
OpenAlexW3177037892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.